Biosimilar Manufacturing solution center
-
Risk-Based Analytical Method Selection In Cleaning Validation Using ASTM International Standards
10/14/2025
This in-depth article describes risk in cleaning and provides a science- and risk-based framework for selecting analytical methods using ASTM International standards.
-
What Can The Tech Sector's 'Minimally Viable' Concept Teach Biopharma?
10/9/2025
Deciding what is good enough to get started can support the mindset of building something without sacrificing quality, functionality, or safety.
-
Fermentation Of Live Biotherapeutic Products In cGMP Environments
10/8/2025
We follow the journey from master cell bank to large-scale anaerobic fermentation, highlighting the unique needs for working with oxygen-sensitive, strictly anaerobic therapeutic microbes in a cGMP setting.
-
What If We Had Just One Developability Parameter?
10/3/2025
Research suggests years-long stability studies that gobble up material can be reduced to a single day using milligram quantities.
-
Trust But Verify: Validating AI In Pharma's GxP World
10/3/2025
Here are practical tips to build validated, transparent, and auditable AI systems that align with GxP principles, paving the way for smarter and more resilient manufacturing processes.
-
Achieve Higher Targeted Concentrations
9/30/2025
Single-pass TFF streamlines downstream processing by reducing footprint, shear exposure, and hold-up volumes. Learn how this approach is advancing efficiency across therapeutic and vaccine production.
-
Automation In The Lab: Lessons From Successes And Setbacks
9/24/2025
Real-world examples show that, in some labs, manual screenings disappeared altogether, replaced by automated runs that now cover entire departments.
-
Can CHO Bioreactors Be Used For Plant-Based Protein Production?
9/22/2025
The moss Physcomitrium patens is especially good at producing glycoproteins. Established technology and prior knowledge are helping one company develop new therapies with it.
-
How To Grow CHO Cells Without Cysteine, Tyrosine Feeds
9/19/2025
Researchers at Pfizer are developing a cell line that synthesizes these amino acids autonomously, which could reduce costs and increase stability.
-
Why FDA's Tough Talk On Foreign Inspections Is More Bark, Less Bite
9/18/2025
FDA Commissioner Marty Makary has promised to end the so-called "double standard" of announced overseas inspections. Does the agency have the resources?